Skip to main content
Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review. Getty Images

Musk’s Neuralink gets FDA’s breakthrough device tag for ‘Blindsight’ implant

Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review but does not confirm a cure for blindness at this time.
Blindsight is a technology designed to help restore limited vision using microelectrode arrays embedded in the visual cortex. Elon Musk claimed that Blindsight could enable those who are blind to see, although experts warn that such claims are premature. Neuralink has not yet released details into when they may begin human trials.

Media Miss by the Left

See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this data
Left 11% Center 33% Right 56%

Bias Distribution

Click to see headlines

Untracked Bias

34 other sources covering this story
Total News Sources 34
Leaning Left 1
Center 3
Leaning Right 5
Last Updated 3 months ago
Bias Distribution Powered by Ground News